{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:43:12Z","timestamp":1792806192592,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ygyno.2026.09.004","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:30:37Z","timestamp":1790634637000},"page":"102-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The diagnostic value of serum glucagon-like peptide-1 (GLP-1) levels in endometrial cancer among obese women"],"prefix":"10.1016","volume":"213","author":[{"given":"Arzu Bostanc\u0131","family":"Durmu\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze Sinem","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2026.09.004_bb0005","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.14.04067","article-title":"Role of body mass index and weight change in the risk of cancer: a systematic review and meta-analysis of 66 cohort studies","volume":"14","author":"Shi","year":"2024","journal-title":"J. Glob. Health"},{"issue":"10","key":"10.1016\/j.ygyno.2026.09.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0333281","article-title":"Current and future burden of gynecological cancers attributable to high body-mass index: a comprehensive global analysis and projection study","volume":"20","author":"Zhao","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ygyno.2026.09.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/09540105.2025.2510961","article-title":"Obesity and endometrial cancer: biological mechanisms, nutritional strategies, and clinical perspectives","volume":"36","author":"Simancas-Racines","year":"2025","journal-title":"Food Agric. Immunol."},{"issue":"10","key":"10.1016\/j.ygyno.2026.09.004_bb0020","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00125-023-05956-x","article-title":"Incretin hormones and type 2 diabetes","volume":"66","author":"Nauck","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.ygyno.2026.09.004_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1465881","article-title":"Glucagon-like peptide-1 receptor agonists in neoplastic diseases","volume":"15","author":"Ji","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ygyno.2026.09.004_bb0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.ygyno.2026.09.004_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.721135","article-title":"GLP-1 receptor agonists: beyond their pancreatic effects","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ygyno.2026.09.004_bb0040","doi-asserted-by":"crossref","first-page":"1431292","DOI":"10.3389\/fendo.2024.1431292","article-title":"Mechanisms of incretin hormones and therapeutic applications of GLP-1","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ygyno.2026.09.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102662","article-title":"Circulating inflammatory markers and risk of endometrial cancer: a systematic review and meta-analysis","volume":"93","author":"Zheng","year":"2024","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ygyno.2026.09.004_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1442814","article-title":"Evaluating pretreatment serum CA-125 levels as prognostic biomarkers in endometrial cancer: a comprehensive meta-analysis","volume":"14","author":"Yu","year":"2024","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.09.004_bb0055","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/dom.15382","article-title":"Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Silverii","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ygyno.2026.09.004_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107401","article-title":"Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: a systematic review and meta-analysis of randomized controlled trials","volume":"208","author":"Figlioli","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"21","key":"10.1016\/j.ygyno.2026.09.004_bb0065","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194743","article-title":"GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research","volume":"135","author":"Valencia-Rinc\u00f3n","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ygyno.2026.09.004_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103419","article-title":"C-reactive protein as a diagnostic and prognostic factor of endometrial cancer","volume":"164","author":"Socha","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2026.09.004_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13112612","article-title":"Obesity as a catalyst for endometrial hyperplasia and cancer progression: a narrative review of epidemiology, molecular pathways, and prevention","volume":"13","author":"Ordeanu","year":"2025","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.ygyno.2026.09.004_bb0080","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ygyno.2026.09.004_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2023.112072","article-title":"Alterations in GLP-1 and PYY release with aging and body mass in the human gut","volume":"578","author":"Jones","year":"2023","journal-title":"Mol. Cell. Endocrinol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582602127X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582602127X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:13:28Z","timestamp":1792804408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582602127X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":17,"alternative-id":["S009082582602127X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.09.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnostic value of serum glucagon-like peptide-1 (GLP-1) levels in endometrial cancer among obese women","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}